Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease

COLAK Y., SENATES E., OZTURK O., DOGANAY H. L., Coskunpinar E. M., Oltulu Y. M., ...More

METABOLIC SYNDROME AND RELATED DISORDERS, vol.10, no.2, pp.103-109, 2012 (SCI-Expanded) identifier identifier identifier


Background: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is one of the most common causes of chronic liver disease, worldwide. Lipoprotein-associated phospholipase A2 (Lp-PLA2) was recently characterized as a novel inflammatory biomarker that is correlated with several components constituting the metabolic syndrome.